Ottobock SE & Co. KGaA | Finanzwire

Basculer en Français

9472	Companies
185369	Keywords
117719	Articles
99261	Press releases

Headlines Articles Press releases Ottobock SE & Co. KGaA

Home
Companies
Ottobock SE & Co. KGaA

BRIEF

published on 11/13/2025 at 07:34, 21 days 21 hours ago

Ottobock Sees Strong Growth in Revenue and Profitability in 9M 2025

EBITDA Margin Product Launches Financial Growth Ottobock 2025 Forecast
PRESS RELEASE

published on 11/13/2025 at 07:29, 21 days 21 hours ago

Ottobock generates strong revenue growth and increases profitability in 9M 2025
Ottobock achieves strong revenue growth and increased profitability in the first nine months of 2025. Key drivers include new product launches and strategic investments

Revenue Growth Profitability MedTech Ottobock 9M 2025
BRIEF

published on 10/24/2025 at 07:49, 1 month 11 days ago

Ottobock Strengthens Investment in NeuroTech Company ONWARD® Medical

Ottobock ONWARD Medical ARC-EX System Spinal Cord Injury NeuroTech Investment
PRESS RELEASE

published on 10/24/2025 at 07:44, 1 month 11 days ago

Ottobock makes follow-on cornerstone investment in NeuroTech company ONWARD® Medical
Ottobock strengthens investment in NeuroTech company ONWARD Medical, supporting innovative therapies for spinal cord injury. Companies deepen strategic partnership for joint innovation in NeuroTech, NeuroOrthotics, and Exoskeletons

Strategic Partnership Investment Ottobock ONWARD Medical NeuroTech
BRIEF

published on 10/10/2025 at 14:50, 1 month 25 days ago

Ottobock Marks Successful IPO on Frankfurt Exchange

Frankfurt Stock Exchange IPO MedTech Ottobock Future Technologies
PRESS RELEASE

published on 10/10/2025 at 14:45, 1 month 25 days ago

Ottobock celebrates successful IPO in Frankfurt
Ottobock celebrates successful IPO in Frankfurt with shares debuting at EUR 72.00. Company aims to invest in future technologies and global patient care network

Innovation IPO MedTech Frankfurt Ottobock
BRIEF

published on 10/07/2025 at 20:05, 1 month 28 days ago

Ottobock Sets IPO Share Price at EUR 66.00

Frankfurt Stock Exchange Share Price Market Capitalization Ottobock IPO Prosthetics Industry
BRIEF

published on 10/07/2025 at 20:02, 1 month 28 days ago

Ottobock Finalizes IPO Price at EUR 66.00 Per Share

Market Capitalization Share Trading Frankfurt Exchange Ottobock IPO Initial Offer
PRESS RELEASE

published on 10/07/2025 at 20:00, 1 month 28 days ago

Ottobock sets final offer price at EUR 66.00 per share
Ottobock sets final offer price for IPO at EUR 66.00 per share with expected market capitalization of EUR 4.2 billion. First day of trading on Frankfurt Stock Exchange scheduled for 9 October 2025

Frankfurt Stock Exchange IPO Share Price Market Capitalization Ottobock
PRESS RELEASE

published on 10/07/2025 at 19:57, 1 month 28 days ago

EQS-Adhoc: Ottobock SE & Co. KGaA: Ottobock sets final offer price at EUR 66.00 per share
Ottobock SE & Co. KGaA sets final offer price at EUR 66 per share for IPO, with total placement volume of EUR 807.6 million. Trading on Frankfurt Stock Exchange under symbol OBCK starts on 9 October 2025

Frankfurt Stock Exchange IPO Final Offer Price Ottobock Symbol OBCK

Accesswire

Published on 12/05/2025 at 02:35, 2 hours 48 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 2 hours 53 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 4 hours 23 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 6 hours 18 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 6 hours 23 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 03:30, 1 hour 52 minutes ago

CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 5 hours 32 minutes ago

EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 20:25, 8 hours 57 minutes ago

Newmark Appoints Globally Recognized Real Estate Executive Peter Trollope to Lead Occupier Solutions
Published on 12/04/2025 at 20:15, 9 hours 8 minutes ago

Galimedix Therapeutics presents compelling Phase 1 study results showing excellent safety and pharmacokinetics with oral small molecule GAL-101 at CTAD 2025
Published on 12/04/2025 at 19:10, 10 hours 12 minutes ago

SCHOTT Pharma’s preliminary results for fiscal year 2025; outlook for FY 2026 and update of mid-term guidance

Les Echos

Published on 12/04/2025 at 18:00, 11 hours 23 minutes ago

Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 11 hours 38 minutes ago

MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 12/04/2025 at 17:44, 11 hours 39 minutes ago

Net profit attributable to owners of the parent up by 63% to €122 million, driven by business resilience and the improvement in Elior's contribution
Published on 12/04/2025 at 07:01, 22 hours 22 minutes ago

bioMérieux launches leading endocrinology testing offer dedicated to enhancing equine health
Published on 12/03/2025 at 18:00, 1 day 11 hours ago

Declaration of voting rights at the end of November 2025

View all LES ECHOS COMFI WIRE